---
title: "Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293615802.md"
description: "A recent collaboration has broadened the reach of crucial genetic testing to support various prominent research initiatives. This partnership aims to make clinically significant genetic testing more accessible to a wider audience. This move is expected to positively impact numerous research programs by providing essential genetic testing services to a larger number of individuals. The expansion is significant for the medical community, as it will allow for the testing of a greater number of individuals, ultimately leading to more comprehensive research outcomes."
datetime: "2026-07-23T12:03:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293615802.md)
  - [en](https://longbridge.com/en/news/293615802.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293615802.md)
generator: "portal-rs"
---

# Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)

A recent collaboration has broadened the reach of crucial genetic testing to support various prominent research initiatives. This partnership aims to make clinically significant genetic testing more accessible to a wider audience. This move is expected to positively impact numerous research programs by providing essential genetic testing services to a larger number of individuals. The expansion is significant for the medical community, as it will allow for the testing of a greater number of individuals, ultimately leading to more comprehensive research outcomes.

### Related Stocks

- [NIKI.US](https://longbridge.com/en/quote/NIKI.US.md)

## Related News & Research

- [Kala Bio signs LOI for exclusive US distribution of Virotek ophthalmology genetic tests](https://longbridge.com/en/news/297646733.md)
- [GDR: Rapid pharmacogenetic testing adoption accelerates, with national and international scale in sight](https://longbridge.com/en/news/297905090.md)
- [Circio boosts circVec gene therapy data and secures funding runway to 2030](https://longbridge.com/en/news/297552739.md)
- [Taysha Gene Therapies highlights TSHA-102 Rett gene therapy path toward BLA submission in corporate presentation](https://longbridge.com/en/news/297550820.md)
- [09:11 ETBioViva Announces U.S. Patent for Klotho Gene Therapy Targeting Age-Related Cognitive Decline](https://longbridge.com/en/news/297657999.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**